-transparent.png){kind=logo}
Survival rates of patients with inoperable, histologically verified bronchial carcinoma are compared as to orthovoltage or megavoltage radiation therapy. With megavoltage therapy, better survival rates are obtained after one or two years; later on, an approximation of the comparison groups is to be observed with regard to life expectancy. The improvement in one-year and two-year survival rates does justify the application of megavoltage therapy.
Related Publications
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
June 1970,
Strahlentherapie,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
April 1982,
Deutsche medizinische Wochenschrift (1946),
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
November 1977,
Osterreichische Zeitschrift fur Onkologie. Austrian journal of oncology,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
January 1965,
Tuberkuloza,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
May 1963,
Der Radiologe,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
December 1980,
European journal of cancer,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
July 1968,
Strahlentherapie,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
March 1970,
Strahlentherapie,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
May 1973,
Strahlentherapie,
G Rey, and
A Voss, and
H Rey, and
H J Untucht, and
P Wöllgens
April 1971,
Praxis der Pneumologie,
